{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:42:19Z","timestamp":1784166139125,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002257","name":"Nickel Producers Environmental Research Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","award":["NPLC-SSS-2019-23"],"award-info":[{"award-number":["NPLC-SSS-2019-23"]}],"id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.lfs.2024.122837","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T12:37:10Z","timestamp":1718282230000},"page":"122837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Compound 3K attenuates isoproterenol-induced cardiac hypertrophy by inhibiting pyruvate kinase M2 (PKM2) pathway"],"prefix":"10.1016","volume":"351","author":[{"given":"Mohd","family":"Rihan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Sunder","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2024.122837_bb0010","first-page":"229","article-title":"Pregnancy-induced physiological hypertrophy protects against cardiac ischemia-reperfusion injury","volume":"7","author":"Xiao","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.lfs.2024.122837_bb0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.12659\/MSMBR.900437","article-title":"Cardiac hypertrophy: An introduction to molecular and cellular basis","volume":"22","author":"Samak","year":"2016","journal-title":"Med. Sci. Monit. Basic Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.122837_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.ph.55.030193.000453","article-title":"Transcriptional regulation during cardiac growth and development","volume":"55","author":"Chien","year":"1993","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122837_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40119-022-00260-y","article-title":"Left ventricular hypertrophy: etiology-based therapeutic options","volume":"11","author":"Sayin","year":"2022","journal-title":"Cardiol Ther"},{"issue":"3","key":"10.1016\/j.lfs.2024.122837_bb0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.20150900","article-title":"The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease","volume":"213","author":"Shirai","year":"2016","journal-title":"J. Exp. Med."},{"issue":"2\u20133","key":"10.1016\/j.lfs.2024.122837_bb0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12307-019-00226-0","article-title":"Pyruvate kinase M2: a metabolic bug in re-wiring the tumor microenvironment","volume":"12","author":"Rihan","year":"2019","journal-title":"Cancer Microenviron."},{"issue":"2","key":"10.1016\/j.lfs.2024.122837_bb0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12265-022-10321-1","article-title":"Role of pyruvate kinase M2 (PKM2) in cardiovascular diseases","volume":"16","author":"Rihan","year":"2023","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.lfs.2024.122837_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128539","article-title":"Boronic acid derivative activates pyruvate kinase M2 indispensable for redox metabolism in oral cancer cells","volume":"59","author":"Rihan","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2024.122837_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.589997","article-title":"PKM2 drives hepatocellular carcinoma progression by inducing immunosuppressive microenvironment","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122837_bb0055","doi-asserted-by":"crossref","first-page":"694","DOI":"10.21873\/invivo.12755","article-title":"PKM2 is overexpressed in glioma tissues, and its inhibition highly increases late apoptosis in U87MG cells with low-density specificity","volume":"36","author":"Park","year":"2022","journal-title":"In Vivo"},{"issue":"1","key":"10.1016\/j.lfs.2024.122837_bb0060","article-title":"Elevated plasma pyruvate kinase M2 concentrations are associated with the clinical severity and prognosis of coronary artery disease","volume":"34","author":"Zhao","year":"2024","journal-title":"Biochem. Med. (Zagreb)"},{"issue":"1","key":"10.1016\/j.lfs.2024.122837_bb0065","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1096\/fj.201902155R","article-title":"Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling","volume":"34","author":"Bhedi","year":"2020","journal-title":"FASEB J."},{"issue":"22","key":"10.1016\/j.lfs.2024.122837_bb0070","doi-asserted-by":"crossref","first-page":"10711","DOI":"10.1111\/jcmm.17007","article-title":"PKM2 promotes angiotensin-II-induced cardiac remodelling by activating TGF-beta\/Smad2\/3 and Jak2\/Stat3 pathways through oxidative stress","volume":"25","author":"Zhang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2024.122837_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116905","article-title":"Cardioprotective potential of compound 3K, a selective PKM2 inhibitor in isoproterenol-induced acute myocardial infarction: a mechanistic study","volume":"485","author":"Rihan","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122837_bb0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00210-023-02593-4","article-title":"Inhibition of pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis","volume":"397","author":"Rihan","year":"2024","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122837_bb0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2017.06.064","article-title":"Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase","volume":"138","author":"Ning","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.lfs.2024.122837_bb0090","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.7150\/ijbs.59855","article-title":"Specific pyruvate kinase M2 inhibitor, compound 3K, induces Autophagic cell death through disruption of the glycolysis pathway in ovarian Cancer cells","volume":"17","author":"Park","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2024.122837_bb0095","doi-asserted-by":"crossref","first-page":"1200538","DOI":"10.3389\/fphar.2023.1200538","article-title":"Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.lfs.2024.122837_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1088","article-title":"Long non-coding RNA VAL facilitates PKM2 enzymatic activity to promote glycolysis and malignancy of gastric cancer","volume":"12","author":"Dai","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.122837_bb0105","doi-asserted-by":"crossref","first-page":"e13548","DOI":"10.1111\/cpr.13548","article-title":"Pyruvate kinase M2 regulates kidney fibrosis through pericyte glycolysis during the progression from acute kidney injury to chronic kidney disease","volume":"57","author":"Chen","year":"2024","journal-title":"Cell Prolif."},{"key":"10.1016\/j.lfs.2024.122837_bb0110","doi-asserted-by":"crossref","unstructured":"F. Xu, M. Guo, W. Huang, L. Feng, J. Zhu, K. Luo, J. Gao, B. Zheng, L.-D. Kong, T. Pang, X. Wu, Q. Xu, Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH, Redox Biol. 36 (2020) 101634.https:\/\/doi.org\/10.1016\/j.redox.2020.101634.","DOI":"10.1016\/j.redox.2020.101634"},{"issue":"null","key":"10.1016\/j.lfs.2024.122837_bb0115","doi-asserted-by":"crossref","first-page":"11697","DOI":"10.2147\/OTT.S240535","article-title":"Simultaneous inhibition of ornithine decarboxylase 1 and pyruvate kinase M2 exerts synergistic effects against hepatocellular carcinoma cells","volume":"13","author":"Zeng","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.lfs.2024.122837_bb0120","article-title":"Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122837_bb0125","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fimmu.2017.00719","article-title":"Toll-like receptor 4 inhibition improves oxidative stress and mitochondrial health in isoproterenol-induced cardiac hypertrophy in rats","volume":"8","author":"Katare","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122837_bb0130","doi-asserted-by":"crossref","first-page":"7856318","DOI":"10.1155\/2020\/7856318","article-title":"Allylmethylsulfide, a sulfur compound derived from garlic, attenuates isoproterenol-induced cardiac hypertrophy in rats","volume":"2020","author":"Mohammed","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2024.122837_bb0135","article-title":"Investigating intestinal inflammation in DSS-induced model of IBD","volume":"60","author":"Kim","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"8","key":"10.1016\/j.lfs.2024.122837_bb0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4330\/wjc.v12.i8.373","article-title":"Sympathetic nervous system activation and heart failure: current state of evidence and the pathophysiology in the light of novel biomarkers","volume":"12","author":"Borovac","year":"2020","journal-title":"World J. Cardiol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122837_bb0145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","article-title":"Adrenergic nervous system in heart failure: pathophysiology and therapy","volume":"113","author":"Lymperopoulos","year":"2013","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.lfs.2024.122837_bb0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00395-019-0730-5","article-title":"Calpains mediate isoproterenol-induced hypertrophy through modulation of GRK2","volume":"114","author":"Aluja","year":"2019","journal-title":"Basic Res. Cardiol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122837_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4149\/gpb_2012_015","article-title":"Morphological and functional characteristics of models of experimental myocardial injury induced by isoproterenol","volume":"31","author":"Nichtova","year":"2012","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.lfs.2024.122837_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.585163","article-title":"Galangin attenuates isoproterenol-induced inflammation and fibrosis in the cardiac tissue of albino Wistar rats","volume":"11","author":"Thangaiyan","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"Suppl. 3","key":"10.1016\/j.lfs.2024.122837_bb0165","article-title":"Sulfur dioxide derivative prevents the prolongation of action potential during the isoproterenol-induced hypertrophy of rat cardiomyocytes","volume":"93","author":"Dalaman","year":"2021","journal-title":"An. Acad. Bras. Cienc."},{"issue":"7","key":"10.1016\/j.lfs.2024.122837_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232507","article-title":"Lack of sexual dimorphism in a mouse model of isoproterenol-induced cardiac dysfunction","volume":"15","author":"Grant","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2024.122837_bb0175","first-page":"H2410","article-title":"Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system","volume":"281","author":"Leenen","year":"2001","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"4","key":"10.1016\/j.lfs.2024.122837_bb0180","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41418-020-00669-9","article-title":"Inhibiting the Pkm2\/b-catenin axis drives in vivo replication of adult cardiomyocytes following experimental MI","volume":"28","author":"Hauck","year":"2021","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.lfs.2024.122837_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13764","article-title":"Inhibiting pyruvate kinase muscle isoform 2 regresses group 2 pulmonary hypertension induced by supra-coronary aortic banding","volume":"234","author":"Xiong","year":"2022","journal-title":"Acta Physiol (Oxford)"},{"issue":"7","key":"10.1016\/j.lfs.2024.122837_bb0190","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1152\/physiolgenomics.00130.2017","article-title":"HIF1 mediates a switch in pyruvate kinase isoforms after myocardial infarction","volume":"50","author":"Williams","year":"2018","journal-title":"Physiol. Genomics"},{"issue":"3","key":"10.1016\/j.lfs.2024.122837_bb0195","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bbrc.2015.02.122","article-title":"A PKM2 signature in the failing heart","volume":"459","author":"Rees","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl_1","key":"10.1016\/j.lfs.2024.122837_bb0200","doi-asserted-by":"crossref","first-page":"A17777","DOI":"10.1161\/circ.148.suppl_1.17777","article-title":"Abstract 17777: Sorafenib aggravates atherosclerotic progression involving with vascular smooth muscle cell (VSMCs) phenotypic switching and proliferation by PKM2-mediated glycolysis","volume":"148","author":"Yu","year":"2023","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.lfs.2024.122837_bb0205","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/CIRCULATIONAHA.121.054885","article-title":"PKM1 exerts critical roles in cardiac remodeling under pressure overload in the heart","volume":"144","author":"Li","year":"2021","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.lfs.2024.122837_bb0210","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1158\/1535-7163.MCT-14-0142","article-title":"Significance of Polypyrimidine tract-binding protein 1 expression in colorectal Cancer","volume":"14","author":"Takahashi","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.lfs.2024.122837_bb0215","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1073\/pnas.0914845107","article-title":"The alternative splicing repressors hnRNP A1\/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism","volume":"107","author":"Clower","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"25","key":"10.1016\/j.lfs.2024.122837_bb0220","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1161\/CIRCULATIONAHA.117.028069","article-title":"Metabolic and proliferative state of vascular adventitial fibroblasts in pulmonary hypertension is regulated through a MicroRNA-124\/PTBP1 (Polypyrimidine tract binding protein 1)\/pyruvate kinase muscle Axis","volume":"136","author":"Zhang","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2024.122837_bb0225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12964-022-00884-6","article-title":"Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin","volume":"20","author":"Alquraishi","year":"2022","journal-title":"Cell Communication and Signaling"},{"issue":"7279","key":"10.1016\/j.lfs.2024.122837_bb0230","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature08697","article-title":"HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer","volume":"463","author":"David","year":"2010","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.lfs.2024.122837_bb0235","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ncb2629","article-title":"ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect","volume":"14","author":"Yang","year":"2012","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122837_bb0240","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20203170","article-title":"Potential role for pyruvate kinase M2 in the regulation of murine cardiac glycolytic flux during in vivo chronic hypoxia","volume":"41","author":"Handzlik","year":"2021","journal-title":"Biosci. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2024.122837_bb0245","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","article-title":"Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1","volume":"145","author":"Luo","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lfs.2024.122837_bb0250","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cmet.2018.01.007","article-title":"Mehal, digoxin suppresses pyruvate kinase M2-promoted HIF-1alpha transactivation in steatohepatitis","volume":"27","author":"Ouyang","year":"2018","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.lfs.2024.122837_bb0255","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood.2021012322","article-title":"PKM2 promotes neutrophil activation and cerebral thromboinflammation: therapeutic implications for ischemic stroke","volume":"139","author":"Dhanesha","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lfs.2024.122837_bb0260","first-page":"22","article-title":"Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect","volume":"9","author":"Luo","year":"2022","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.lfs.2024.122837_bb0265","article-title":"Role of PKM2-mediated Immunometabolic reprogramming on development of cytokine storm","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122837_bb0270","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/jleuko\/qiad054","article-title":"PKM2 promotes proinflammatory macrophage activation in ankylosing spondylitis","volume":"114","author":"Weng","year":"2023","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122837_bb0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","article-title":"Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the Warburg effect in LPS-activated macrophages","volume":"21","author":"Palsson-McDermott","year":"2015","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.lfs.2024.122837_bb0280","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1194\/jlr.RA119000382","article-title":"Role of pyruvate kinase M2 in oxidized LDL-induced macrophage foam cell formation and inflammation","volume":"61","author":"Kumar","year":"2020","journal-title":"J. Lipid Res."},{"issue":"19","key":"10.1016\/j.lfs.2024.122837_bb0285","doi-asserted-by":"crossref","first-page":"9331","DOI":"10.7150\/thno.60385","article-title":"Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts","volume":"11","author":"Satyanarayana","year":"2021","journal-title":"Theranostics"},{"issue":"38","key":"10.1016\/j.lfs.2024.122837_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo0987","article-title":"PKM2 promotes pulmonary fibrosis by stabilizing TGF-beta1 receptor I and enhancing TGF-beta1 signaling","volume":"8","author":"Gao","year":"2022","journal-title":"Sci. Adv."},{"issue":"Suppl_1","key":"10.1016\/j.lfs.2024.122837_bb0295","doi-asserted-by":"crossref","first-page":"A10231","DOI":"10.1161\/circ.144.suppl_1.10231","article-title":"Abstract 10231: Parp1-Pkm2 axis mediates right ventricular failure associated with pulmonary arterial hypertension","volume":"144","author":"Shimauchi","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.lfs.2024.122837_bb0300","first-page":"384","article-title":"PARP1-PKM2 Axis mediates right ventricular failure associated with pulmonary arterial hypertension, JACC: basic to translational","volume":"7","author":"Shimauchi","year":"2022","journal-title":"Science"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524004272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524004272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T01:04:00Z","timestamp":1728176640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524004272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":59,"alternative-id":["S0024320524004272"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122837","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compound 3K attenuates isoproterenol-induced cardiac hypertrophy by inhibiting pyruvate kinase M2 (PKM2) pathway","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122837"}}